.jpg)
Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
Company is investing more than €100 million in the expansion of the Halle site
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
The company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.
Govt committed to supporting pharma companies with industry-friendly policies
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
It is a two dose vaccine to be administered intramuscularly at 28 days apart
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Subscribe To Our Newsletter & Stay Updated
